Periodic Reporting for period 1 - TIR-C (NEXT GENERATION TOPICAL MEDICATION TO TREAT IMMUNE RESPONSES IN ATOPIC DERMATITIS – THE MOST COMMON CAUSE OF ECZEMA)

Atopic Dermatitis (AD) is one of the most common chronic skin diseases. The prevalence of AD has shown 3x growth in the last 30 years, currently affecting 10-20% of children and 3-5% adults globally. AD poses a huge burden on societies and patients’ quality of life, due to...